Sana Biotechnology, Inc. (the “Company”) intends ... of Ÿ Genome modification efforts to date have II expression CD47 generally been incomplete Ÿ Autologous therapies have limited ...

The allogeneic cell therapy field received a welcome “shot in the arm” this week as Sana Biotechnology ... 4.7bn acquisition of Forty Seven and its CD47 programs, which has yielded no ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 45.04% ...

We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid-cap stocks. As the name suggests, smid-cap stocks have a valuation ...

Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $3.25, but opened at $3.15. Sana Biotechnology ...

Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.16 which represents a decrease of $-0.09 or -2.77% from the prior close of $3.25. The stock opened at $3.15 and touched a low of ...

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ:SANA). Such investors are ...

Sana Biotechnology (SANA) and eBay (EBAY) are two of the stocks rallying this morning despite the market's losses. Sana is soaring nearly 250%, while eBay is climbing a much more modest 12%.